Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Sumansetron These highlights do not include all the information needed to use ONDANSETRON TABLETS, USP safely and effectively. See full prescribing information for ONDANSETRON TABLETS, USP. ONDANSETRON tablets USP, for oral use Initial U.S. Approval: 1991
Medication labelWhy this: Advisory · dailymed-prescription
Sumatriptan tablets are indicated for the acute treatment of migraine attacks with or without aura in adults. Sumatriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS ). Safety and effectiveness of sumatriptan tablets have not been established for cluster headache, which is present in an older, predominantly male population.
- generic_name
- sumatriptan succinate, ondansetron
- brand_name
- Sumatriptan Succinate, Ondansetron
- product_names
- sumatriptan succinate, ondansetron, Sumatriptan Succinate, Ondansetron
- ndc
- 45963-538, 59088-772, 59088-772-00, 55111-292, 55111-292-09, 45963-538-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en